CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $390,000 | -77.1% | 28,400 | -68.0% | 0.01% | -80.0% |
| Q1 2016 | $1,705,000 | +508.9% | 88,826 | +2817.1% | 0.03% | +1400.0% |
| Q3 2015 | $280,000 | -54.3% | 3,045 | -56.3% | 0.00% | -60.0% |
| Q2 2015 | $613,000 | -24.6% | 6,973 | -36.3% | 0.01% | -37.5% |
| Q1 2015 | $813,000 | +74.8% | 10,955 | +32.0% | 0.01% | +166.7% |
| Q4 2014 | $465,000 | -45.5% | 8,300 | -55.9% | 0.00% | -40.0% |
| Q3 2014 | $853,000 | -41.1% | 18,800 | -46.3% | 0.01% | -28.6% |
| Q2 2014 | $1,449,000 | +546.9% | 35,000 | +982.6% | 0.01% | +600.0% |
| Q1 2014 | $224,000 | -32.7% | 3,233 | -40.9% | 0.00% | -50.0% |
| Q3 2013 | $333,000 | – | 5,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |